Status:
COMPLETED
Follow-up at School-age of Children Who Participated in the Efficacy Study of Nitric Oxide for Premature Infants
Lead Sponsor:
University of Chicago
Collaborating Sponsors:
Mallinckrodt
Conditions:
Prematurity, Respiratory Distress Syndrome,Hypoxemia
Eligibility:
All Genders
4-6 years
Phase:
PHASE3
Brief Summary
Our previous data demonstrated that premature infants treated with inhaled nitric oxide at birth had improved neurodevelopmental outcomes at two years corrected age. We now wish to determine whether t...
Detailed Description
Two questionnaires (truncated versions of previously validated surveys), one for parent and another for teacher, for which written consent was previously obtained are being sent to parents. The teache...
Eligibility Criteria
Inclusion
- Children who participated in NOVA study and are of school age
Exclusion
- Children who participated in NOVA study but deceased post discharge
Key Trial Info
Start Date :
May 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2006
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT00152542
Start Date
May 1 2005
End Date
September 1 2006
Last Update
June 12 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The University of Chicago, Comer Children's Hospital,
Chicago, Illinois, United States, 60637